Journal article
Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies
Abstract
RATIONALE & OBJECTIVE: The role of plasma soluble tumor necrosis factor receptor 1 (sTNFR1) and sTNFR2 in the prognosis of clinical events after hospitalization with or without acute kidney injury (AKI) is unknown.
STUDY DESIGN: Prospective cohort.
Authors
Coca SG; Vasquez-Rios G; Mansour SG; Moledina DG; Thiessen-Philbrook H; Wurfel MM; Bhatraju P; Himmelfarb J; Siew E; Garg AX
Journal
American Journal of Kidney Diseases, Vol. 81, No. 2, pp. 190–200
Publisher
Elsevier
Publication Date
February 2023
DOI
10.1053/j.ajkd.2022.08.007
ISSN
0272-6386